Impact of Overnight Home Closed Loop (CL) Insulin Delivery on Glycaemic Control and Counter-Regulatory Hormones Compared to Sensor Augmented Pump Therapy with Low Glucose Suspend (SAP-LGS) in Patients with Type 1 Diabetes (T1D) (#89)